Here are four takeaways from the report.
1. Global spending on oncology therapeutics and supportive care drugs reached $113 billion in 2016, up $6 billion from the year prior.
2. Over the past five years, the total global cost of cancer medicines increased at a constant annual growth rate of nearly 9 percent, according to the report.
3. Overall, the United States accounts for nearly half of the total global oncology costs.
4. The report projects total global spending for oncologics and supportive care will exceed $147 billion by 2021.
Access the full report here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.